Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2017

May 25, 2017

32093_dirs_2017-05-24_85d9ec08-33b0-459f-9a64-34cb74f4d729.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-05-22

Reporting Person: DUGGAN ROBERT W (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-22 Common Stock P 27928 $26.149 Acquired 3054244 Direct
2017-05-22 Common Stock P 6800 $26.667 Acquired 3061044 Direct
2017-05-23 Common Stock P 18600 $26.688 Acquired 3079644 Direct
2017-05-23 Common Stock P 28600 $27.628 Acquired 3108244 Direct
2017-05-23 Common Stock P 2000 $28.074 Acquired 3110244 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 35000 Indirect

Footnotes

F1: This is the weighted average purchase price of the shares, which ranged from $25.45 to $26.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F2: This is the weighted average purchase price of the shares, which ranged from $26.46 to $26.819 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F3: This is the weighted average purchase price of the shares, which ranged from $26.172 to $27.082 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F4: This is the weighted average purchase price of the shares, which ranged from $27.19 to $28.014 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F5: This is the weighted average purchase price of the shares, which ranged from $28.035 to $28.182 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F6: Shares are held by Genius Accelerated LLC, of which the Reporting Person is the sole member and beneficiary.